VPC-18005

VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain, and disrupts the ERG binding to DNA. VPC-18005 is a potent inhibitor of luciferase activity.


Cat. No.: EX-A6580	Purity: >98%

	Chemical structure of VPC-18005

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	850	In-stock
100mg	1350	In-stock
200mg	2050	In-stock
500mg	2950	In-stock
1g	4200	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2242480-48-2
Purity	>98%
Formula	C15H17N3O3S
Mol Weight	319.379
Color	White to off-white
State	solid powder
Solubility	Soluble in DMSO 62.5 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder 4°C, protect from light; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Miriam S Butler, et al. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer. Oncotarget. 2017 Jun 27;8(26):42438-42454.
CoA	CoA of VPC-18005


		Search